These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31093890)

  • 1. Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures.
    Pardo J; Mena A; Jiménez E; Aymar N; Ortiz I; Roncero R; Mestre F; Vidal M
    Clin Transl Oncol; 2019 Nov; 21(11):1568-1572. PubMed ID: 31093890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning.
    Prieto I; Pardo J; Luna J; Marin JP; Olivera J; Garcia AJ; Perez AM
    Scand J Pain; 2016 Apr; 11():52-58. PubMed ID: 28850470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study.
    Mercadante S; Aielli F; Adile C; Costanzi A; Casuccio A
    J Pain Symptom Manage; 2016 Jul; 52(1):27-34. PubMed ID: 27208863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
    Mercadante S; Prestia G; Adile C; Casuccio A
    J Pain; 2014 Jun; 15(6):602-7. PubMed ID: 24561001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.
    Radbruch L; Torres LM; Ellershaw JE; Gatti A; Luis Lerzo G; Revnic J; Taylor D
    Support Care Cancer; 2012 Mar; 20(3):565-73. PubMed ID: 21424794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl pectin nasal spray for breakthrough cancer pain.
    Taylor DR; Gabrail N
    Future Oncol; 2012 Feb; 8(2):121-30. PubMed ID: 22335576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study.
    Fallon M; Reale C; Davies A; Lux AE; Kumar K; Stachowiak A; Galvez R;
    J Support Oncol; 2011; 9(6):224-31. PubMed ID: 22055892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain.
    Portenoy RK; Burton AW; Gabrail N; Taylor D;
    Pain; 2010 Dec; 151(3):617-624. PubMed ID: 20800358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.
    Taylor D; Radbruch L; Revnic J; Torres LM; Ellershaw JE; Perelman M
    J Pain Symptom Manage; 2014 Jun; 47(6):1001-7. PubMed ID: 24128821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.
    Bossi P; Locati L; Bergamini C; Mirabile A; Granata R; Imbimbo M; Resteghini C; Licitra L
    Oral Oncol; 2014 Sep; 50(9):884-7. PubMed ID: 25001894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.
    Mazzola R; Ricchetti F; Fiorentino A; Giaj-Levra N; Fersino S; Tebano U; Albanese S; Gori S; Alongi F
    Clin Transl Oncol; 2017 May; 19(5):593-598. PubMed ID: 27853984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients.
    Portenoy RK; Raffaeli W; Torres LM; Sitte T; Deka AC; Herrera IG; Wallace MS;
    J Opioid Manag; 2010; 6(5):319-28. PubMed ID: 21046929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fentanyl inhalant for the treatment of breakthrough cancer pain: a multicenter, randomized, double-blind, placebo-controlled trial.
    Lin R; Song B; Li N; Rong B; Bai J; Liu Y; Wang W; Liu A; Luo S; Liu B; Cheng P; Wu Y; Li Y; Yu X; Liu X; Dai X; Li X; Liu D; Wang J; Huang Y
    BMC Palliat Care; 2024 Sep; 23(1):222. PubMed ID: 39244530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
    Masel EK; Landthaler R; Gneist M; Watzke HH
    Support Care Cancer; 2018 Feb; 26(2):491-497. PubMed ID: 28849261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of fentanyl buccal soluble film in cancer patients with inadequate breakthrough pain control.
    Chiang YH; Lien CT; Su WH; Yen TY; Chen YJ; Lai YL; Lim KH; Dai KY; Chung HP; Hung CY; Leu YS
    BMC Palliat Care; 2024 Jun; 23(1):150. PubMed ID: 38877477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
    Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
    Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer.
    Pointreau Y; Bensadoun RJ; Bera G; Sire C; Ruffier A; Janoray G; Calais G; Bollet M; Pinel B; Braniste V; Amores X
    Patient Prefer Adherence; 2020; 14():859-868. PubMed ID: 32546980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
    Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.
    Minkowitz H; Bull J; Brownlow RC; Parikh N; Rauck R
    Support Care Cancer; 2016 Jun; 24(6):2669-75. PubMed ID: 26780504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.